If you’ve spent enough time in Kuala Lumpur, you know that the city is a restless beast – loud, chaotic, always moving. It’s ...
Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback